CD137 is expressed in follicular dendritic cell tumors and in classical Hodgkin and T-cell lymphomas: Diagnostic and therapeutic implications

American Journal of Pathology

Volumn 181, Issue 3, 2012, Pages 795-803

  Anderson, Matthew W ^a   Zhao, Shuchun ^a   Freud, Aharon G ^a   Czerwinski, Debra K ^a   Kohrt, Holbrook ^a   Alizadeh, Ash A ^a   Houot, Roch ^b,c   Azambuja, Denize ^d   Biasoli, Irene ^d   Morais, Jos Carlos ^d   Spector, Nelson ^d   Molina Kirsch, Hernan F ^e   Warnke, Roger A ^a   Levy, Ronald ^a   Natkunam, Yasodha ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RENNES UNIVERSITY HOSPITAL   (France)

^c INSERM U917   (France)

^d FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^e San Juan Hospital   (Guatemala)

Author keywords

[No Author keywords available]

Indexed keywords

CD137 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CELL MATURATION; CELL SUSPENSION; CLASSICAL HODGKIN LYMPHOMA; CONTROLLED STUDY; FOLLICULAR DENDRITIC CELL; FOLLICULAR DENDRITIC CELL SARCOMA; GERMINAL CENTER; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; NATURAL KILLER CELL; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; T CELL LYMPHOMA; T LYMPHOCYTE; THYMOCYTE; TISSUE SECTION; TUMOR CELL;

ANTIGENS, CD137; DENDRITIC CELLS, FOLLICULAR; FLOW CYTOMETRY; HISTIOCYTIC DISORDERS, MALIGNANT; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE SUBSETS; LYMPHOID TISSUE; LYMPHOMA, B-CELL; LYMPHOMA, T-CELL; TUMOR MARKERS, BIOLOGICAL;

EID: 84865215820     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.05.015     Document Type: Article

References (45)

1. B.A. Garni-Wagner, Z.H. Lee, Y.J. Kim, C. Wilde, C.Y. Kang, B.S. Kwon 4-1BB is expressed on CD45RAhiROhi transitional T cell in humans Cell Immunol 169 1996 91 98
2. X. Zhang, C.J. Voskens, M. Sallin, A. Maniar, C.L. Montes, Y. Zhang, W. Lin, G. Li, E. Burch, M. Tan, R. Hertzano, A.I. Chapoval, K. Tamada, B.R. Gastman, D.H. Schulze, S.E. Strome CD137 promotes proliferation and survival of human B cells J Immunol 184 2010 787 795
3. W. Lin, C.J. Voskens, X. Zhang, D.G. Schindler, A. Wood, E. Burch, Y. Wei, L. Chen, G. Tian, K. Tamada, L.X. Wang, D.H. Schulze, D. Mann, S.E. Strome Fc-dependent expression of CD137 on human NK cells: insights into "agonistic" effects of anti-CD137 monoclonal antibodies Blood 112 2008 699 707
4. A. Maniar, X. Zhang, W. Lin, B.R. Gastman, C.D. Pauza, S.E. Strome, A.I. Chapoval Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement Blood 116 2010 1726 1733
5. M. Lindstedt, B. Johansson-Lindbom, C.A. Borrebaeck Expression of CD137 (4-1BB) on human follicular dendritic cells Scand J Immunol 57 2003 305 310
6. G. Kienzle, J. von Kempis CD137 (ILA/4-1BB), expressed by primary human monocytes, induces monocyte activation and apoptosis of B lymphocytes Int Immunol 12 2000 73 82
7. S. Pauly, K. Broll, M. Wittmann, G. Giegerich, H. Schwarz CD137 is expressed by follicular dendritic cells and costimulates B lymphocyte activation in germinal centers J Leukoc Biol 72 2002 35 42
8. D. Drenkard, F.M. Becke, J. Langstein, T. Spruss, L.A. Kunz-Schughart, T.E. Tan, Y.C. Lim, H. Schwarz CD137 is expressed on blood vessel walls at sites of inflammation and enhances monocyte migratory activity FASEB J 21 2007 456 463
9. J. von Kempis, H. Schwarz, M. Lotz Differentiation-dependent and stimulus-specific expression of ILA, the human 4-1BB-homologue, in cells of mesenchymal origin Osteoarthritis Cartilage 5 1997 394 406
10. C. Reali, M. Curto, V. Sogos, F. Scintu, S. Pauly, H. Schwarz, F. Gremo Expression of CD137 and its ligand in human neurons, astrocytes, and microglia: modulation by FGF-2 J Neurosci Res 74 2003 67 73
11. C. Wang, G.H. Lin, A.J. McPherson, T.H. Watts Immune regulation by 4-1BB and 4-1BBL: complexities and challenges Immunol Rev 229 2009 192 215
12. H.W. Lee, S.J. Park, B.K. Choi, H.H. Kim, K.O. Nam, B.S. Kwon 4-1BB promotes the survival of CD8+ T lymphocytes by increasing expression of Bcl-xL and Bfl-1 J Immunol 169 2002 4882 4888
13. B.K. Choi, Y.H. Kim, P.M. Kwon, S.C. Lee, S.W. Kang, M.S. Kim, M.J. Lee, B.S. Kwon 4-1BB functions as a survival factor in dendritic cells J Immunol 182 2009 4107 4115
14. R.A. Wilcox, A.I. Chapoval, K.S. Gorski, M. Otsuji, T. Shin, D.B. Flies, K. Tamada, R.S. Mittler, H. Tsuchiya, D.M. Pardoll, L. Chen Cutting edge: expression of functional CD137 receptor by dendritic cells J Immunol 168 2002 4262 4267
15. D.H. Lynch The promise of 4-1BB (CD137)-mediated immunomodulation and the immunotherapy of cancer Immunol Rev 222 2008 277 286
16. I. Melero, W.W. Shuford, S.A. Newby, A. Aruffo, J.A. Ledbetter, K.E. Hellstrom, R.S. Mittler, L. Chen Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors Nat Med 3 1997 682 685
17. O. Murillo, A. Arina, S. Hervas-Stubbs, A. Gupta, B. McCluskey, J. Dubrot, A. Palazn, A. Azpilikueta, M.C. Ochoa, C. Alfaro, S. Solano, J.L. Prez-Gracia, B.O. Oyajobi, I. Melero Therapeutic antitumor efficacy of anti-CD137 agonistic monoclonal antibody in mouse models of myeloma Clin Cancer Res 14 2008 6895 6906
18. R. Houot, M.J. Goldstein, H.E. Kohrt, J.H. Myklebust, A.A. Alizadeh, J.T. Lin, J.M. Irish, J.A. Torchia, A. Kolstad, L. Chen, R. Levy Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by Treg depletion Blood 114 2009 3431 3438
19. A.A. Alizadeh, A.J. Gentles, A.J. Alencar, C.L. Liu, H.E. Kohrt, R. Houot, M.J. Goldstein, S. Zhao, Y. Natkunam, R.H. Advani, R.D. Gascoyne, J. Briones, R.J. Tibshirani, J.H. Myklebust, S.K. Plevritis, I.S. Lossos, R. Levy Prediction of survival in diffuse large B-cell lymphoma based on the expression of two genes reflecting tumor and microenvironment Blood 118 2011 1350 1358
20. O. Murillo, J. Dubrot, A. Palazn, A. Arina, A. Azpilikueta, C. Alfaro, S. Solano, M.C. Ochoa, C. Berasain, I. Gabari, J.L. Prez-Gracia, P. Berraondo, S. Hervs-Stubbs, I. Melero In vivo depletion of DC impairs the anti-tumor effect of agonistic anti-CD137 mAb Eur J Immunol 39 2009 2424 2436
21. L. Zhang, Q. Wang, X. Wang, P. Ding, J. Song, C. Ma, W. Sun Anti-CD137 monoclonal antibody promotes the direct anti-tumor effect mediated by peripheral blood-derived human dendritic cells in vitro Cell Mol Immunol 1 2004 71 76
22. A. Palazn, A. Teijeira, I. Martnez-Forero, S. Hervs-Stubbs, C. Roncal, I. Peuelas, J. Dubrot, A. Morales-Kastresana, J.L. Prez-Gracia, M.C. Ochoa, L. Ochoa-Callejero, A. Martnez, A. Luque, J. Dinchuk, A. Rouzaut, M. Jure-Kunkel, I. Melero Agonist anti-CD137 mAb act on tumor endothelial cells to enhance recruitment of activated T lymphocytes Cancer Res 71 2011 801 811
23. K. Broll, G. Richter, S. Pauly, F. Hofstaedter, H. Schwarz CD137 expression in tumor vessel walls High correlation with malignant tumors Am J Clin Pathol 115 2001 543 549
24. Z. Zhou, S. Kim, J. Hurtado, Z.H. Lee, K.K. Kim, K.E. Pollok, B.S. Kwon Characterization of human homologue of 4-1BB and its ligand Immunol Lett 45 1995 67 73
25. Y. Natkunam, R.A. Warnke, K. Montgomery, B. Falini, M. van De Rijn Analysis of MUM1/IRF4 protein expression using tissue microarrays and immunohistochemistry Mod Pathol 14 2001 686 694
26. D. Azambuja, I.S. Lossos, I. Biasoli, J.C. Morais, L. Britto, A. Scheliga, W. Pulcheri, Y. Natkunam, N. Spector Human germinal center-associated lymphoma protein expression is associated with improved failure-free survival in Brazilian patients with classical Hodgkin lymphoma Leuk Lymphoma 50 2009 1830 1836
27. S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, J. Thiele, J.W. Vardiman, WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues 2008 IARC Press Lyon
28. Y.J. Liu, J. Xu, O. de Bouteiller, C.L. Parham, G. Grouard, O. Djossou, B. de Saint-Vis, S. Lebecque, J. Banchereau, K.W. Moore Follicular dendritic cells specifically express the long CR2/CD21 isoform J Exp Med 185 1997 165 170
29. A. Traverse-Glehen, S. Pittaluga, P. Gaulard, L. Sorbara, M.A. Alonso, M. Raffeld, E.S. Jaffe Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma Am J Surg Pathol 29 2005 1411 1421
30. L. Quintanilla-Martinez, D. de Jong, A. de Mascarel, E.D. Hsi, P. Kluin, Y. Natkunam, M. Parrens, S. Pileri, G. Ott Gray zones around diffuse large B cell lymphoma Conclusions based on the workshop of the XIV meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux, France J Hematop 2 2009 211 236
31. G. Pallesen, O. Myhre-Jensen Immunophenotypic analysis of neoplastic cells in follicular dendritic cell sarcoma Leukemia 1 1987 549 557
32. H. Yu, J.A. Gibson, G.S. Pinkus, J.L. Hornick Podoplanin (D2-40) is a novel marker for follicular dendritic cell tumors Am J Clin Pathol 128 2007 776 782
33. H.J. Gruss, I. Scheffrahn, G. Hubinger, J. Duyster, F. Hermann The CD30 ligand and CD40 ligand regulate CD54 surface expression and release of its soluble form by cultured Hodgkin and Reed-Sternberg cells Leukemia 10 1996 829 835
34. C. Grant, K. Dunleavy, F.C. Eberle, S. Pittaluga, W.H. Wilson, E.S. Jaffe Primary mediastinal large B-cell lymphoma, classic Hodgkin lymphoma presenting in the mediastinum, and mediastinal gray zone lymphoma: what is the oncologist to do? Curr Hematol Malig Rep 6 2011 157 163
35. J. Cossman, C.M. Annunziata, S. Barash, L. Staudt, P. Dillon, W.W. He, P. Ricciardi-Castagnoli, C.A. Rosen, K.C. Carter Reed-Sternberg cell genome expression supports a B-cell lineage Blood 94 1999 411 416
36. R. Kuppers, K. Rajewsky, M. Zhao, G. Simons, R. Laumann, R. Fischer, M.L. Hansmann Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development Proc Natl Acad Sci USA 91 1994 10962 10966
37. M.E. Kadin, L. Muramoto, J. Said Expression of T-cell antigens on Reed-Sternberg cells in a subset of patients with nodular sclerosing and mixed cellularity Hodgkin's disease Am J Pathol 130 1988 345 353
38. N. Asano, A. Oshiro, K. Matsuo, Y. Kagami, F. Ishida, R. Suzuki, T. Kinoshita, Y. Shimoyama, J. Tamaru, T. Yoshino, K. Kitamura, H. Fukutani, Y. Morishima, S. Nakamura Prognostic significance of T-cell or cytotoxic molecules phenotype in classical Hodgkin's lymphoma: a clinicopathologic study J Clin Oncol 24 2006 4626 4633
39. S. Nakamura, M. Nagahama, Y. Kagami, Y. Yatabe, T. Takeuchi, M. Kojima, T. Motoori, R. Suzuki, H. Taji, M. Ogura, Y. Mizoguchi, M. Okamoto, H. Suzuki, A. Oyama, M. Seto, Y. Morishima, T. Koshikawa, T. Takahashi, S. Kurita, T. Suchi Hodgkin's disease expressing follicular dendritic cell marker CD21 without any other B-cell marker: a clinicopathologic study of nine cases Am J Surg Pathol 23 1999 363 376
40. I. Schwering, A. Bruninger, U. Klein, B. Jungnickel, M. Tinguely, V. Diehl, M.L. Hansmann, R. Dalla-Favera, K. Rajewsky, R. Kppers Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma Blood 101 2003 1505 1512
41. R. Kppers, A. Bruninger, M. Mschen, V. Distler, M.L. Hansmann, K. Rajewsky Evidence that Hodgkin and Reed-Sternberg cells in Hodgkin disease do not represent cell fusions Blood 97 2001 818 821
42. R. Houot, H. Kohrt, M.J. Goldstein, R. Levy Immunomodulating antibodies and drugs for the treatment of hematological malignancies Cancer Metastasis Rev 30 2011 97 109
43. U.H. Lee, K.B. Kwack, J.W. Park, B.S. Kwon Molecular cloning of agonistic and antagonistic monoclonal antibodies against human 4-1BB Eur J Immunogenet 29 2002 449 452
44. U.H. Lee, J.H. Son, J.J. Lee, B. Kwon, J.W. Park, B. Se Kwon Humanization of antagonistic anti-human 4-1BB monoclonal antibody using a phage-displayed combinatorial library J Immunother 27 2004 201 210
45. Q. Wang, P. Zhang, Q. Zhang, X. Wang, J. Li, C. Ma, W. Sun, L. Zhang Analysis of CD137 and CD137L expression in human primary tumor tissues Croat Med J 49 2008 192 200